D. Batchelor

539 total citations
9 papers, 400 citations indexed

About

D. Batchelor is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, D. Batchelor has authored 9 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in D. Batchelor's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and Immune Cell Function and Interaction (3 papers). D. Batchelor is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and Immune Cell Function and Interaction (3 papers). D. Batchelor collaborates with scholars based in Netherlands and United Kingdom. D. Batchelor's co-authors include Michael Kersten, Florry A. Vyth‐Dreese, Johan Sein, W J Nooijen, P. W. Kershaw, Jos H. Beijnen, J. A. G. Watt, Virginie M.M. Herben, John Loudon and Hilde Rosing and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Acta Psychiatrica Scandinavica.

In The Last Decade

D. Batchelor

9 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Batchelor Netherlands	7	185	93	75	68	68	9	400
Kok Haw Jonathan Lim United Kingdom	12	180 1.0×	31 0.3×	45 0.6×	19 0.3×	17 0.3×	33	435
Fabien Rondepierre France	11	21 0.1×	43 0.5×	93 1.2×	71 1.0×	26 0.4×	26	309
Kristen P. Hook United States	11	34 0.2×	34 0.4×	54 0.7×	36 0.5×	15 0.2×	32	369
Amy Perrin Ross United States	12	59 0.3×	30 0.3×	42 0.6×	19 0.3×	32 0.5×	35	425
Christine Choi United States	13	48 0.3×	31 0.3×	208 2.8×	62 0.9×	5 0.1×	28	498
Akiko Fujisawa Japan	10	68 0.4×	7 0.1×	50 0.7×	23 0.3×	16 0.2×	17	339
Jonathan Charles Goddard United Kingdom	9	23 0.1×	56 0.6×	87 1.2×	14 0.2×	74 1.1×	48	403
Alshimaa Mostafa Egypt	8	46 0.2×	25 0.3×	31 0.4×	70 1.0×	6 0.1×	17	254
Shahzeb Hassan United States	14	48 0.3×	10 0.1×	80 1.1×	67 1.0×	10 0.1×	49	456
Christopher W. Perrett United Kingdom	11	24 0.1×	46 0.5×	130 1.7×	36 0.5×	20 0.3×	22	360

Countries citing papers authored by D. Batchelor

Since Specialization

Citations

This map shows the geographic impact of D. Batchelor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Batchelor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Batchelor more than expected).

Fields of papers citing papers by D. Batchelor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Batchelor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Batchelor. The network helps show where D. Batchelor may publish in the future.

Co-authorship network of co-authors of D. Batchelor

This figure shows the co-authorship network connecting the top 25 collaborators of D. Batchelor. A scholar is included among the top collaborators of D. Batchelor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Batchelor. D. Batchelor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Batchelor, D., Michael Kersten, Florry A. Vyth‐Dreese, et al.. (2003). Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma. British Journal of Cancer. 88(2). 175–180. 36 indexed citations

Batchelor, D.. (2001). Hair and cancer chemotherapy: consequences and nursing care - a literature study. European Journal of Cancer Care. 10(3). 147–163. 145 indexed citations

Gast, G C de, Heinz‐Josef Klümpen, Florry A. Vyth‐Dreese, et al.. (2000). Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.. PubMed. 6(4). 1267–72. 48 indexed citations

Herben, Virginie M.M., Hilde Rosing, W.W. ten Bokkel Huinink, et al.. (1999). Oral topotecan: bioavailability and effect of food co-administration. British Journal of Cancer. 80(9). 1380–1386. 50 indexed citations

Batchelor, D., et al.. (1997). ["Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy". Marylin J. Dodd et al. Report of discussion of this article in the IKA Nursing Research Utilization Board].. PubMed. 14(3). 16–8. 1 indexed citations

Kruit, Wim H.J., R. L. H. Bolhuis, Slinger Jansen, et al.. (1993). Interleukin-2-induced thyroid dysfunction is correlated with treatment duration but not with tumor response.. Journal of Clinical Oncology. 11(5). 921–924. 19 indexed citations

Jansen, Rob L. H., P.H.M. de Mulder, D. Batchelor, et al.. (1992). Repetitive Weekly Cycles of 4-Day Continuous Infusion of Recombinant Interleukin-2: A Phase I Study. Journal of Immunotherapy. 12(4). 277–284. 6 indexed citations

Stoter, G., et al.. (1992). Treatment of disseminated renal cell cancer with combinations of interleukin-2, lymphokine-activated killer cells, and alpha-interferon.. PubMed. 378. 225–33. 2 indexed citations

McCreadie, Robin G., D. Wiles, Zahid Mahmood, et al.. (1989). The Scottish first episode schizophrenia study. Acta Psychiatrica Scandinavica. 80(6). 597–602. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact